Published in Cancer Weekly, November 27th, 2001
For the 9 months ended September 30, 2001, the company reported a net loss of $14.8 million, or $0.64 per share, compared with a net loss of $18.4 million, or $1.13 per share, for the same period last year. Included in the net loss for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.